R&D generates a wealth of vital data, which is pivotal to everything else a life sciences organisation does. Yet there is often great diversity in the way this is collected, retained and accessed. This lack of consistency compromises the ability to track products effectively, both within the business and out in the market. The new ISO Identification of Medicinal Products (IDMP) standards couldn’t have come at a better time then, says Steve Scribner, life sciences advisor to AMPLEXOR Group.
https://international-pharma.com/wp-content/uploads/2016/07/Tech-1-Reinventing.pdf